Dublin, March 10, 2017 -- Research and Markets has announced the addition of the "Global Markets for Generic Drugs" report to their offering.
This report discusses the implications of all the above-mentioned trends, in the context of the current size and growth of the generics market, both in global terms and analyzed by the most important national markets. The nature and structure of the generics industry is discussed, with profiles of the leading 20+ generics companies and an update on M&A activity. Five-year sales forecasts are provided for the national markets and the major therapeutic categories of products involved.
Report Includes
- An overview of the global markets for generic drugs, including coverage of therapeutics such as antibacterials, antidepressants, anticancer agents, anti-arthritics, cardiovascular drugs (e.g., hypolipidaemics and antihypertensives), and drugs for respiratory conditions, including asthma and COPD
- Analyses of global market trends, with data from 2015, estimates for 2016, and projections of compound annual growth rates (CAGRs) through 2021
- Examination of strategies employed by companies specializing in generics to meet the challenges of this highly competitive market, while also summarizing strategies employed by originator companies to forestall generic competition
- Discussion of important trends by product categories and major country markets, acknowledging that Brazil, China, India, Mexico, and Russia are among the rising markets for generic activity
- Profiles of major players and leading generics companies
- A look at recent merger and acquisition activity
Key Topics Covered:
1: Introduction
- Study Goals And Objectives
- Reasons For Doing The Study
- Scope Of Report
- Market Analyses And Forecasts
- Methodology
- Intended Audience
- Information Sources
2: Summary
- Market Size And Evolution
Overview
- Recent History Of The Generics Sector
4: The New Generics Era
- The Patent Cliff
- Types Of Generics
5: Major Generic Issues
- Regulatory Environment
- Patents And IP
6: The Generics Market
- Global Pharmaceutical And Generics Market
- Market Opportunities By Product Class
7: Generics Markets And Forecasts By Country
- Americas
- Asia
- Europe
8: The Global Generics Industry
- Trends
- Structure Of The Generics Industry
- Recent M&A Activity
- Brand Company Involvement
- Profiles Of The Leading Generics Companies
- Other International Generics Companies
For more information about this report visit http://www.researchandmarkets.com/research/k6whpb/global_markets
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Generic Drugs


Elon Musk Faces French Probe Over X and Grok Amid Rising U.S.-EU Tensions
Florida Investigates OpenAI and ChatGPT Over Alleged Role in FSU Shooting
Kakaku.com Stock Surges on EQT Takeover Interest Amid Rising Japan Deal Activity
European Car Sales Surge in March as EV and Hybrid Demand Accelerates
Apple Stock Dips as Tim Cook Steps Down, John Ternus Named Next CEO
Microsoft Commits $18 Billion to Expand AI and Cloud Infrastructure in Australia
Amazon Expands AI Bet with Up to $25 Billion Investment in Anthropic
John Ternus Signals Apple’s Future with Product-First AI Strategy
J.P. Morgan Downgrades Essity AB on Rising Costs and Weak Earnings Outlook
SpaceX President Gwynne Shotwell Earns $85.8M as IPO Buzz Grows
Tesla Q1 Earnings Preview: Robotaxi Delays and SpaceX Merger Speculation Grow
China Food Delivery Stocks Dip as Regulators Crack Down on “Ghost Deliveries”
OPmobility Reports Q1 Revenue Dip Amid Automotive Industry Slowdown
LG Innotek Stock Hits Record High on $68M Automotive Wi-Fi 7 Deal
SpaceX Eyes $60B Cursor Deal to Boost AI Power Ahead of IPO
SK Hynix to Invest $13 Billion in AI Chip Packaging Facility
Samsung Boosts DRAM Supply to Tesla as AI-Driven Memory Demand Surges 



